WAT Waters Corporation
Healthcare$338.64-1.09%ClosedMarket Cap: $22.07B
As of 2026-05-26
Valuation
P/E (TTM)
28.46
PEG
37.86
P/B
1.84
P/S
5.92
EV/EBITDA
29.67
DCF Value
$248.75
FCF Yield
1.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.0%
Operating Margin
17.1%
Net Margin
11.9%
ROE
8.0%
ROA
1.8%
ROIC
2.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.27B | 47.0% | $-47.0M | $-72.0M | $— | — |
| Q4 null | $932.4M | 59.8% | $310.6M | $225.2M | $— | — |
| FY null | $3.17B | 57.8% | $893.2M | $642.6M | $— | — |
| Q3 null | $799.9M | 59.0% | $192.1M | $148.9M | $— | — |
| Q2 null | $771.3M | 58.3% | $188.2M | $147.1M | $— | — |
| Q1 null | $661.7M | 58.2% | $151.7M | $121.4M | $— | — |
| Q4 null | $872.7M | 60.1% | $292.3M | $231.4M | $— | — |
| FY null | $2.96B | 59.4% | $826.4M | $637.8M | $— | — |
| Q3 null | $740.3M | 59.3% | $211.1M | $161.5M | $— | — |
| Q2 null | $708.5M | 59.3% | $189.1M | $142.7M | $— | — |
| Q1 null | $636.8M | 58.9% | $133.8M | $102.2M | $— | — |
| Q4 2023 | $819.5M | 61.2% | $264.2M | $216.2M | $3.65 | — |